Publications

Patient versus Healthcare Professional Spontaneous Adverse Drug Reaction Reporting: A systematic review

• Author

  Inch J Watson M Anakwe-Umeh Hazell L on behalf of the Yellow Card Study Collaboration

  Inch J Watson M Anakwe-Umeh Hazell L on behalf of the Yellow Card Study Collaboration

• Cite

  Drug Saf. 2012 Oct 1;35(10):807-18

Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia

• Author

  Shakir S Marshall V Camm AJ Kannankeril PJ Dalageorgou C Jamshidi Y Bastiaenen R Jeffery S Nolte IM Zheng D Johnson T Ruddy S Talott D Norris KJ Snieder H George AL Munroe PB Roden DM and Behr ER

  Shakir S Marshall V Camm AJ Kannankeril PJ Dalageorgou C Jamshidi Y Bastiaenen R Jeffery S Nolte IM Zheng D Johnson T Ruddy S Talott D Norris KJ Snieder H George AL Munroe PB Roden DM Behr ER

• Cite

  Journal of the American College of Cardiology. 2012 Aug 28;60(9):841-50

Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes

• Author

  Shakir S Mackenzie IS MacDonald TM Dryburgh M Mantay BJ McDonnell P and Layton D

  Shakir S Mackenzie IS MacDonald TM Dryburgh M Mantay BJ McDonnell P Layton D

• Cite

  British Journal of Clinical Pharmacology, May 2012; 73(5):801-11

A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes Kääb

• Author

  Shakir S Behr ER Marshall V Camm AJ Ritchie MD Crawford DC Sinner MF Kannankeril PJ Wilde AA Bezzina CR Schulze-Bahr E Zumhagen S Guicheney P Bishopric NH Dalageorgou C Jamshidi Y Myerburg RJ Schott JJ Steinbeck G Norris K Jeffery S George AL Jr Roden DM. Kääb S1 Pfeufer A Beckmann BM Martens E Zhang T Stallmeyer B Denjoy I Bardai A Van Gelder IC Perz S Lichtner P Meitinger T Peters A Wichmann HE Ingram C Bradford Y Carter S

  Shakir S Behr ER Marshall V Camm AJ Ritchie MD Crawford DC Sinner MF Kannankeril PJ Wilde AA Bezzina CR Schulze-Bahr E Zumhagen S Guicheney P Bishopric NH Dalageorgou C Jamshidi Y Myerburg RJ Schott JJ Steinbeck G Norris K Jeffery S George AL Jr Roden DM. Kääb S1 Pfeufer A Beckmann BM Martens E Zhang T Stallmeyer B Denjoy I Bardai A Van Gelder IC Perz S Lichtner P Meitinger T Peters A Wichmann HE Ingram C Bradford Y Carter S

• Cite

  Circulation: Cardiovascular Genetics. 2012 Feb 1;5(1):91-9

Free to view

Modified Prescription-Event Monitoring Studies: a tool for Pharmacovigilance and Risk Management

• Author

  Layton D Hazell L and Shakir S

  Layton D Hazell L Shakir S

• Cite

  Drug Safety. 2011 December 1;34(12)

Examining the utilization and tolerability of the non-sedating antihistamine levocetirizine in England using prescription-event monitoring data

• Author

  Osborne V Layton D Gilchrist A & Shakir S

  Osborne V Layton D Gilchrist A Shakir S

• Cite

  Drug Safety. 2011 Dec 1;34(12):1177-89

Risk of depressive episodes with rimonabant: a before and after modified prescription-event monitoring study conducted in England

• Author

  Buggy Y Cornelius V Wilton L and Shakir S

  Buggy Y Cornelius V Wilton L Shakir S

• Cite

  Drug Safety. 2011 Jun 1;34(6):501-9

Paediatric post-marketing pharmacovigilance: comparison of the adverse event profile of vigabatrin prescribed to children and adults

• Author

  Aurich-Barrera B Wilton L Brown D and Shakir S

  Aurich-Barrera B Wilton L Brown D Shakir S

• Cite

  Pharmacoepidemiology and Drug Safety. 2011 Jun;20(6):608-18

New postgraduate qualifications in pharmacovigilance from the Drug Safety Research Unit in the UK

• Author

  Lynn E Layton D and Shakir S

  Lynn E Layton D Shakir S

• Cite

  Drug Safety. 2011 Jan 1;34(1):89-91

Hypoglycaemia with pioglitazone: analysis of data from the Prescription-Event Monitoring study.

• Author

  Shakir S. Cornelius V Kasliwal R Wilton L Vlckova V

  Shakir S Cornelius V Kasliwal R Wilton L Vlckova V

• Cite

  J Eval Clin Pract. 2010 Dec;16(6):1124-8

Paediatric postmarketing pharmacovigilance using prescription-event monitoring: a comparison of the adverse event profiles of lamotrigine prescribed in children and adults in England

• Author

  Aurich-Barrera B Wilton L Brown D and Shakir S

  Aurich-Barrera B Wilton L Brown D Shakir S

• Cite

  Drug Safety. 2010 Sep 1;33(9):751-63

Adverse drug reaction reporting in the UK: A retrospective observational comparison of Yellow Card Reports submitted by patients and healthcare professionals

• Author

  Hannaford P McLernon D Bond C Watson M Lee A Hazell L and Avery A on behalf of the Yellow Card Collaboration

  Hannaford P McLernon D Bond C Watson M Lee A Hazell L Avery A on behalf of the Yellow Card Collaboration

• Cite

  Drug Safety. 2010 Sep 1;33(9):775-88

Incidence of venous thromboembolism in users of strontium ranelate: an analysis of data from a prescription-event monitoring study in England

• Author

  Osborne V Layton D Wilton L and Shakir S Perrio M

  Osborne V Layton D Wilton L Shakir S Perrio M

• Cite

  Drug Safety. 2010 Jul 1;33(7):579-91

Safety profile of oxcarbazepine: results from a prescription-event monitoring study

• Author

  Layton D Buggy Y Fogg C and Shakir S

  Layton D Buggy Y Fogg C Shakir S

• Cite

  Epilepsia. 2010 May;51(5):818-29

Drug Utilization of Intrinsa (Testosterone Patch) In England: Interim analysis of a Prescription-Event Monitoring Study to support Risk Management

• Author

  Osborne V Hazell L Layton D and Shakir S

  Osborne V Hazell L Layton D Shakir S

• Cite

  Drug Saf. 2010 Mar 1;33(3):213-21

Systematic reviews of adverse effects of drug interventions: a survey of their conduct and reporting quality Cornelius

• Author

  Shakir SA Cornelius VR Perrio MJ Smith LA

  Shakir SA Cornelius VR Perrio MJ Smith LA

• Cite

  Pharmacoepidemiol Drug Saf. 2009 Dec;18(12)

Strontium ranelate as a cause of acute renal failure and dress syndrome

• Author

  Buggy Y Iyer D O'Reilly K Searle M

  Buggy Y Iyer D O'Reilly K Searle M

• Cite

  Nephrology (Carlton). 2009 Sep;14(6):624

The safety profile of tadalafil as prescribed in general practice in England: results from a prescription-event monitoring study involving 16 129 patients.

• Author

  Hazell L Shakir SA. Cornelius V Wilton LV

  Hazell L Shakir SA Cornelius V Wilton LV

• Cite

  BJU Int. 2009 Feb;103(4):506-14

Pattern of drug utilisation for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy

• Author

  Fogg C Dodoo AN Asiimwe A Nartey ET Kodua A Tenkorang O Ofori-Adjei D

  Fogg C Dodoo AN Asiimwe A Nartey ET Kodua A Tenkorang O Ofori-Adjei D

• Cite

  Malar J. 2009 Jan 5;8:2

Safety Profile of Varenicline as used in General Practice in England: Interim Results from a Prescription-Event Monitoring Study

• Author

  Shakir S Kasliwal R Wilton L

  Shakir S Kasliwal R Wilton L

• Cite

  Drug Safety. 2009;32(6):499-507

Hypoglycaemia with anti-diabetic drugs: Results from Prescription-Event Monitoring cohorts of rosiglitazone, pioglitazone, nateglinide and repaglinide

• Author

  Shakir S Cornelius V Kasliwal R Wilton L Vickova V

  Shakir S Cornelius V Kasliwal R Wilton L Vickova V

• Cite

  Drug Safety. 2009;32(5):409-18

Risk management and outcomes of adverse events to Pioglitazone in Primary Care in the UK; an observational study

• Author

  Fogg C Shakir SA Kasliwal R

  Fogg C Shakir SA Kasliwal R

• Cite

  Drug Safety. 2009;32(3):229-37

Neuraminidase inhibitors: widespread use for influenza may reveal more adverse effects

• Author

  Layton D Cox A

  Layton D Cox A

• Cite

  The Pharmaceutical Journal. January 2009

Use and risk management of Carvedilol for the treatment of heart failure in the community in England: results from a modified prescription-event monitoring study

• Author

  Shakir SA Aurich-Barrera B Wilton LV

  Shakir SA Aurich-Barrera B Wilton LV

• Cite

  Drug Safety. 2009;32(1):43-54.

Antipsychotics and stroke: the story to date

• Author

  Layton D Cox A

  Layton D Cox A

• Cite

  The Pharmaceutical Journal. January 2009